Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Travel stocks soar as encouraging vaccine study lifts Europe

Wed, 15th Jul 2020 09:41

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Euro zone blue-chips hit highest since March 5

* Italy's Atlantia soars as end of concession dispute nears

* Sweden's SEB slips as loan loss provision surges

* All eyes on ECB meeting, EU summit later this week
(Updates to market close)

By Sruthi Shankar

July 15 (Reuters) - European stocks closed at over a
five-week high on Wednesday, with travel stocks surfing a wave
of optimism following reports of progress in developing a
COVID-19 vaccine.

Hard-hit airline stocks like British Airways-owner IAG
, Ryanair and Lufthansa rose between
9.7% and 10.7%, while cruise operator Carnival Plc
jumped 11.4%.

The travel & leisure index surged 6.1% to lead
sectoral gains, but still remains the worst performer in Europe
this year with a 33% plunge as the coronavirus pandemic brought
global travel to a halt.

The pan-European STOXX 600 rose 1.8%, closing just
short of levels last seen in early March, while euro zone
blue-chips jumped 1.7% to hit their highest level
since March 5.

Investors were encouraged by an early-stage study on U.S.
biotech firm Moderna Inc's experimental vaccine for
COVID-19 that provoked immune responses.

Meanwhile, AstraZeneca jumped 5.2% after a report
said positive news on the University of Oxford's potential
COVID-19 vaccine that has been licensed to the drugmaker could
be announced as soon as Thursday.

"Our central scenario is that a vaccine would be broadly
available from the second quarter of next year, or the fourth
quarter of this year in our upside scenario," Mark Haefele,
chief investment officer of UBS Global Wealth Management, told
clients.

"Various potential treatment options are also in the
pipeline, raising hopes that societies can cope with the
pandemic without full shutdowns."

Expectations were also high among investors heading into an
EU summit later this week that leaders will agree on a recovery
fund of 750 billion euros for pandemic-hammered economies.

The European Central Bank concludes its policy meeting on
Thursday although no major announcements are expected.

Among individual movers, Swedish telecom operator Tele2 AB
gained 2.9% as it reaffirmed its 2020 earnings
outlook and plans for an extra shareholder payout.

The world's largest fish farmer Mowi ASA jumped
6.8% as harvest volumes beat its own forecast. Shares in peer
Salmar rose 2.2%.

The top gainer on the STOXX 600 was Atlantia SpA,
which shot up 26.7% after the Italian infrastructure group and
its unit Autostrade made the government new offers to settle
their long-running dispute.

Semiconductor equipment maker ASML Holding NV
declined 3.7% as it reported quarterly profit below estimates,
but forecast overall growth for 2020.

Swedish bank SEB AB fell 1.6% after reporting a
smaller-than-expected fall in net quarterly profit, but credit
loss provisions surged. Handelsbanken AB also dropped
2.6%.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak
Dasgupta and Catherine Evans)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.